首页> 美国卫生研究院文献>AAPS PharmSciTech >Investigation of Formulation Variables and Excipient Interaction on the Production of Niosomes
【2h】

Investigation of Formulation Variables and Excipient Interaction on the Production of Niosomes

机译:脂质体生产中配方变量和辅料相互作用的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study was to investigate the effects of formulation and process variables on the properties of niosomes formed from Span 40 as nonionic surfactant. A variety of formulations encapsulating Paclitaxel, a hydrophobic model drug, were prepared using different dicetyl phosphate (DCP) and Span 40-cholesterol (1:1) amounts. Formulations were optimized by multiple regression analysis to evaluate the changes on niosome characteristics such as entrapment efficiency, particle size, polydispersity index, zeta potential and in vitro drug release. Multiple regression analysis revealed that as Span 40-cholesterol amounts in the formulations were increased, zeta potential and percent of drug released at 24th hour were decreased. Besides, DCP was found to be effective on increasing niosome size. As a process variable, the effect of sonication was observed and findings revealed an irreversible size reduction on Span 40 niosomes after probe sonication. Monodisperse small sized (133 ± 6.01 nm) Span 40 niosomes entrapping 98.2% of Paclitaxel with a weight percentage of 3.64% were successfully prepared. The drug–excipient interactions in niosomes were observed by differential scanning calorimetry and X-ray powder diffraction analysis. Both techniques suggest the conversion of PCTs’ crystal structure to amorphous form. The thermal analyses demonstrate the high interaction between drug and surfactant that explains high entrapment efficiency. After 3-month storage, niosomes preserved their stability in terms of drug amount and particle size. Overall, this study showed that Span 40 niosomes with desired properties can be prepared by changing the content and production variables.
机译:这项研究的目的是研究配方和工艺变量对由Span 40作为非离子表面活性剂形成的脂质体的性能的影响。使用不同的磷酸二鲸蜡酯(DCP)和Span 40-胆固醇(1:1)的量,可以制备多种封装紫杉醇(一种疏水性模型药物)的制剂。通过多重回归分析对制剂进行优化,以评估脂质体特性的变化,例如包封率,粒径,多分散指数,ζ电势和体外药物释放。多元回归分析显示,随着配方中Span 40胆固醇含量的增加,ζ电位和第24小时释放的药物百分数降低。此外,发现DCP对增加脂质体尺寸有效。作为一个过程变量,观察到了超声处理的效果,发现表明探针进行超声处理后,Span 40脂质体的尺寸不可逆地减小。成功制备了捕获98.2%紫杉醇,重量百分比为3.64%的单分散小粒径(133±6.01 nm)跨度40脂质体。通过差示扫描量热法和X射线粉末衍射分析观察到了脂质体中药物-赋形剂的相互作用。两种技术都建议将PCT的晶体结构转换为无定形形式。热分析表明药物和表面活性剂之间的高相互作用,这说明了高的包封率。储存3个月后,脂质体在药物量和粒径方面保持了稳定性。总体而言,这项研究表明,可以通过更改含量和生产变量来制备具有所需特性的Span 40脂质体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号